 | • レポートコード：MRC2304K086 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：物流 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界のバイオ医薬品3PL市場規模が、予測期間中にCAGR 7%以上で成長すると予測しています。本資料では、バイオ医薬品3PLの世界市場について多角的に調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、機能別（国内輸送管理、国際輸送管理、付加価値倉庫&物流）分析、サプライチェーン別（コールドチェーン、非コールドチェーン）分析、地域別（北米、南米、ヨーロッパ、アジア太平洋、中東・アフリカ、アメリカ、カナダ、メキシコ、ブラジル、アルゼンチン、イギリス、ドイツ、フランス、ロシア、スペイン、サウジアラビア、UAE、カタール、南アフリカ、インド、中国、シンガポール、日本、韓国、ベトナム、オーストラリア）分析、競争状況、市場機会・将来の動向など、以下の内容を記載しています。なお、参入企業情報として、DHL、FedEx、UPS、Kuehne + Nagel、DB Schenker、Nippon Express、Ceva Logistics、Kerry Logistics、Agility、XPO Logisticsなどが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のバイオ医薬品3PL市場規模：機能別 - 国内輸送管理の市場規模 - 国際輸送管理の市場規模 - 付加価値付き倉庫&物流の市場規模 ・世界のバイオ医薬品3PL市場規模：サプライチェーン別 - コールドチェーンの市場規模 - 非コールドチェーンの市場規模 ・世界のバイオ医薬品3PL市場規模：地域別 - 北米のバイオ医薬品3PL市場規模 アメリカのバイオ医薬品3PL市場規模 カナダのバイオ医薬品3PL市場規模 メキシコのバイオ医薬品3PL市場規模 … - 南米のバイオ医薬品3PL市場規模 ブラジルのバイオ医薬品3PL市場規模 アルゼンチンのバイオ医薬品3PL市場規模 … - ヨーロッパのバイオ医薬品3PL市場規模 イギリスのバイオ医薬品3PL市場規模 ドイツのバイオ医薬品3PL市場規模 フランスのバイオ医薬品3PL市場規模 … - 中東・アフリカのバイオ医薬品3PL市場規模 サウジアラビアのバイオ医薬品3PL市場規模 UAEのバイオ医薬品3PL市場規模 カタールのバイオ医薬品3PL市場規模 … - アジア太平洋のバイオ医薬品3PL市場規模 インドのバイオ医薬品3PL市場規模 中国のバイオ医薬品3PL市場規模 シンガポールのバイオ医薬品3PL市場規模 … ・競争状況 ・市場機会・将来の動向 |
The biopharmaceutical 3PL market is expected to register a CAGR of more than 7%. The rising trend of outsourcing logistics, the focus of pharmaceutical players on their distribution networks due to their strong sales numbers, and the rise in the number of biosimilar launches are some of the key factors driving the market.
The COVID-19 outbreak also had a major impact on global logistics in part due to reduced air freight capacity and reduced workforce at airports, ports, and warehouses. Small players in the biopharmaceutical third-party logistics market were hit severely as they usually do not have any recovery, backup, or intermittent operation plan.
Technological advancements are also one of the key factors driving the adoption of temperature management logistic services. Technologies such as warehouse robotics, mobile cloud solutions, data mining, and real-time monitoring have changed the overall logistics industry to a great extent. According to a global survey carried out in July 2021, cold chain services are important to third-party logistics providers (3PLs). More than 62% of 3PL service providers believe cold chain services are critically important for the future growth of their business.
Pharmaceutical 3PL Market Trends
Growth in Demand During the Pandemic
In 2020, the warehousing and storage segment dominated the market for biopharmaceutical third-party logistics (3PL) and held the largest revenue share of 43.6%. This is attributed to a large demand for 3PL services from the pharmaceutical and healthcare industries. To reduce the operating costs and the company’s overheads, the life sciences companies are opting for third-party logistic services.
With a surge in demand, the service providers have enhanced their offerings with many value-added services, such as warehousing and packaging. Moreover, to minimize the hassle and reduce the turnaround time, the providers have installed barcode scanners and robots for picking and aligning the products from distant locations.
Pharmaceutical companies pay a lot of attention to packaging quality in terms of purity, uniformity, shelf-life, integrity, and packaging standard of their products. This is expected to boost the market over the forecast period. The 3PL service providers are investing a lot in providing value-added services, which is another key market driver. For instance, Expeditors, a service-based provider of value-added services ranging from simple to complex, offers a range of logistics delivery models that enhance customer services while mitigating transportation and inventory costs. Growing pharmaceutical industries are also driving the market. According to industry sources, in 2021, most of the demand was generated from North America (mainly from the United States), followed by Europe, Africa, and Asia-Pacific.
Top Regional Markets
North America dominated the biopharmaceutical third-party logistics (3PL) market and accounted for the largest revenue share of 41.5% in 2020. This is majorly attributed to the dominance of the region in the biologics and pharmaceutical drugs market and an increase in exports and imports of biopharmaceuticals.
Furthermore, owing to high healthcare expenditure, the adoption of advanced technologies is quite high in the region. Thus, for the improvement of warehousing and transportation, North America-based pharmaceutical companies are relying more on 3PL service providers, which is driving the regional growth. Additionally, the presence of major players is also responsible for the growth of the market for biopharmaceutical third-party logistics (3PL) in the region.
Moreover, in Asia-Pacific, the market for biopharmaceutical third-party logistics (3PL) witnessed the second-largest revenue of USD 15.4 billion in 2020, and it is also expected to witness the fastest CAGR of 7.2% over the forecast period. The growing demand for medicines among the aging population, adoption of technologically advanced services, and growing economic conditions in emerging countries such as China, Japan, and India are among the few factors responsible for its fastest growth rate.
Furthermore, due to the increased demand for healthcare, the pharmaceutical sector continues to grow, in turn, resulting in the growth of the 3PL market. Global pharmaceutical sales grew by 7.7% in 2021. In addition, in 2021, established markets saw an average revenue increase of 6.4%, and emerging markets’ revenue grew by 11.9%. The United States, Japan, China, Germany, and France are the world’s top five pharmaceutical markets in terms of 2021 sales. In 2021, the United States had 46.8% of global sales.
Pharmaceutical 3PL Market Competitor Analysis
The market for biopharmaceutical third-party logistics (3PL) is fragmented, with the presence of a large number of players. This fragmentation causes hindrances for big players to enter a few countries across the world. Thus, the big players are undergoing consolidation that will help them accept modern technologies from small or regional players and expand their global presence.
Companies such as FedEx, DHL, and DB Schenker are a few of the renowned companies in the pharmaceutical 3PL market across the world.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
2.1 Analysis Methodology
2.2 Research Phases
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
4.1 Market Overview
4.2 Technological Trends
4.3 Government Regulations and Initiatives (Related to Transportation and Storage of Pharmaceutical Products)
4.4 Impact of COVID-19 on the Market (Including Short-term and Long-term Effects on the Market and the Economy)
4.5 Pharmaceutical E-commerce Market (Market Trends and their Impact on Logistics/Delivery Market)
4.6 Spotlight on Packaging of Pharmaceuticals (Global and Regional Trends)
4.7 Industry Supply Chain/Value Chain Analysis (includes Analysis on Distribution Models and Key Players in each step of the Value Chain)
4.8 Insights into Reverse/Return Logistics in the Pharma Industry
5 MARKET DYNAMICS
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Industry Attractiveness – Porter’s Five Forces Analysis
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Consumers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Intensity of Competitive Rivalry
6 MARKET SEGMENTATION (Market Size by Value)
6.1 Function
6.1.1 Domestic Transportation Management
6.1.2 International Transportation Management
6.1.3 Value-added Warehousing and Distribution
6.2 Supply Chain
6.2.1 Cold Chain
6.2.2 Non-cold Chain
6.3 Geography
6.3.1 North America
6.3.1.1 United States
6.3.1.2 Canada
6.3.1.3 Mexico
6.3.2 South America
6.3.2.1 Brazil
6.3.2.2 Argentina
6.3.2.3 Rest of South America
6.3.3 Europe
6.3.3.1 United Kingdom
6.3.3.2 Germany
6.3.3.3 France
6.3.3.4 Russia
6.3.3.5 Spain
6.3.3.6 Rest of Europe
6.3.4 Middle-East
6.3.4.1 Saudi Arabia
6.3.4.2 United Arab Emirates
6.3.4.3 Qatar
6.3.4.4 South Africa
6.3.4.5 Rest of Middle-East
6.3.5 Asia-Pacific
6.3.5.1 India
6.3.5.2 China
6.3.5.3 Singapore
6.3.5.4 Japan
6.3.5.5 South Korea
6.3.5.6 Vietnam
6.3.5.7 Australia
6.3.5.8 Rest of Asia-Pacific
7 COMPETITIVE LANDSCAPE
7.1 Overview (Market Concentration and Major Players)
7.2 Company Profiles
7.2.1 DHL
7.2.2 FedEx
7.2.3 UPS
7.2.4 Kuehne + Nagel
7.2.5 DB Schenker
7.2.6 Nippon Express
7.2.7 Ceva Logistics
7.2.8 Kerry Logistics
7.2.9 Agility
7.2.10 XPO Logistics
7.3 Other Companies (Overview/Key Information)
8 FUTURE OF THE MARKET
9 APPENDIX